Latest News

At first-ever public hearing on CBD, advocates and FDA try to blaze trail to regulatory compromise

SILVER SPRING, Md. — By 10:30 a.m., a panel of the Food and Drug Administration’s top regulators had already heard from more than 50 different people, all eager to squeeze their hopes or concerns about CBD, the booming marijuana-adjacent compound companies are suddenly adding to everything from dog food to dietary supplements, into the short speaking time they were granted.

There were mothers claiming marijuana drove their children to suicide, millennial entrepreneurs who struggled for a good answer when regulators asked what effect CBD has in cosmetics, and high-paid industry lawyers pitching well-vetted regulatory frameworks. More than 60 more people were still scheduled to speak.

Read the rest…

Source link

Related posts

Medical News Today: What are the benefits of pistachios?


People With Asthma At Higher Risk Of Becoming Obese, Study Suggests


Global EPA and DHA Omega-3 Ingredient Market 2015-2016 – Forecasts to 2019 –


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy